Clinical Trial Update: Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intraperitoneal delivery of Alimta (pemetrexed) with cisplatin and paclitaxel as first-line therapy for stage III ovarian cancer; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Alimta (pemetrexed)
• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Arizona | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 1 | Status: COMPLETED | Results posted: 2013-07-19